ChiCTR2200063370
尚未开始
/
/
/
2022-09-05
/
/
possible sarcopenia or at risk of fall
Effectiveness of telehealth in preventive care: A randomised controlled trial of tele-exercise programme involving elderly with possible sarcopenia or at risk of fall
Effectiveness of telehealth in preventive care: A randomised controlled trial of tele-exercise programme involving elderly with possible sarcopenia or at risk of fall
Primary objective 1. to evaluate the effectiveness of tele-exercise on physical function and exercise adherence among the elderly with possible sarcopenia or at risk of fall in comparison with a community-based group. Secondary objectives 2. To evaluate the elderly’s experience with tele-exercise, with an emphasis on their psychological welfare, social wellbeing, and acceptance of the telehealth approach.
整群随机抽样
Ⅰ期
In order to avoid contamination among recruited subjects from the 10 community centres, subjects were randomized by locations using a simple random drawing procedure.
Assessors will be blinded for the treatment of the participants.
Health and Medical Research Fund, Health Bureau, The Government of the Hong Kong Special Administrative Region
/
48
/
2022-07-04
2024-07-03
/
1. permanent residents of Hong Kong 2. aged 65 years or above living independently at home 3. diagnosed with possible sarcopenia and/or having either a fall in the past year or fear of falling with a score of >= 20 points on FES-I 4. able to speak and listen to Cantonese 5. able to walk without mobility aids in their home;
登录查看1. diagnosed with dementia or cognitive impairment 2. severe vision impairments that do not permit the using of tablet, reading of the exercise-booklet, and completing the activity diaries 3. unable to pass the preparticipation Health Screening of American College of Sport Medicine (ACSM) 4. regular physical activities in the past 6 months based on the definition of WHO (Word Health Organization 2020).;
登录查看College of Professional and Continuing Education, The Hong Kong Polytechnic University
/
PDL1 三阴性乳腺癌 atezolizumab
BioArtMED2025-06-21
糖尿病 GLP-1/GIP
恒瑞医药2025-06-21
肥胖 Wegovy
一度医药2025-06-21
ADA 糖尿病
箕星药业科技2025-06-21
乙肝 乙肝疫苗
肝脏时间2025-06-21
药物临床试验
Insight数据库2025-06-21
B细胞恶性肿瘤 自身免疫性疾病 Capstan
博生吉细胞研究2025-06-21
结节性硬化症 三叉神经痛 BD项目
美柏资本2025-06-21
正大天晴药业集团2025-06-21